Benchtop System Prepares Samples for the Life Technologies SOLiD Sequencer

DANVERS, Mass. – SPRIworks Fragment Library System III from Beckman Coulter Genomics automates the preparation of libraries for the Life Technologies SOLiD* Sequencer. With the introduction of this third system in a series, researchers can use the SPRIworks system to automate library preparation for the three major next generation sequencing platforms.

Combining Solid Phase Reversible Immobilization (SPRI) chemistry and Beckman Coulter automation, SPRIworks System III facilitates the construction of consistent, quality libraries. Automating the library construction process saves researchers valuable time. One to ten samples can be completed within three and a half hours, and the process provides several size-selection and nick translation options.

Earlier this year, Beckman Coulter Genomics introduced SPRIworks Fragment Library Systems I and II, which automate library preparation for the Illumina Genome Analyzer and the Roche GS FLX** DNA Sequencer, respectively. Like those products, System III utilizes a dedicated, color-coded method card and cartridges. Thus, library construction for all three sequencing platforms can be conducted using one instrument and the appropriate method card and cartridges.

SPRIworks Fragment Library System III is a validated plug-and-play system: users simply insert the method card, samples and adapters; select run options; and press start.

“With the introduction of SPRIworks System III, researchers can automate the construction of libraries for all three major sequencing platforms,” commented Julie Moore, director of marketing for Beckman Coulter Genomics. “Using the same system and processes will increase productivity and provide scientists with the tools for consistent, quality library construction.”

About Beckman Coulter Genomics

Beckman Coulter Genomics, headquartered in Danvers, Massachusetts, is a leading provider of genomic services and nucleic acid purification products, serving life-science researchers and the pharmaceutical industry throughout the world. The company, a wholly owned subsidiary of Beckman Coulter, was created by combining Beckman Coulter’s Agencourt Bioscience with Cogenics. By providing technical expertise, combined with personalized service, Beckman Coulter Genomics delivers the highest quality data, robust analyses and innovative thinking. For more information, visit www.beckmangenomics.com.

About Beckman Coulter, Inc.

Beckman Coulter, Inc., based in Orange County, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies (including reagent test kits), service and operating-type lease payments, represent about 80 percent of the company’s 2009 revenue of $3.3 billion. For more information, visit www.beckmancoulter.com.

*SOLiD is a trademark of Life Technologies.

**GS FLX is a trademark of Roche.

Beckman Coulter, SPRI, SPRI-TE, SPRIworks, Agencourt and the stylized logo are registered trademarks of Beckman Coulter, Inc.